Related Experiment Videos
Immunologic studies on a pancreatic oncofetal protein
Journal of the National Cancer Institute
|June 1, 1978
Summary
Researchers identified a novel pancreatic oncofetal protein (POP) in fetal pancreas and pancreatic cancer extracts. This protein shows potential as a biomarker for pancreatic carcinoma detection.
Area of Science:
- Biochemistry
- Immunology
- Oncology
Background:
- Human fetal pancreas contains unique antigens.
- Pancreatic carcinoma shares antigens with fetal pancreas.
Purpose of the Study:
- To identify and characterize a specific antigen in human fetal pancreas and pancreatic carcinoma.
- To develop a method for detecting this antigen.
Main Methods:
- Rabbit immunization with human fetal pancreas extract.
- Immunoelectrophoresis and counterimmunoelectrophoresis for antigen detection.
- Ammonium sulfate precipitation and ion-exchange chromatography for partial purification.
- Trypsin treatment to assess protein nature.
Main Results:
- An antibody was produced against an antigen present in fetal pancreas and pancreatic carcinoma.
- The antigen, termed pancreatic oncofetal protein (POP), was identified in the alpha1-alpha2 region.
- POP was partially purified using centrifugation, salt precipitation, and chromatography.
- Antigenic activity was lost upon trypsin treatment, indicating a protein nature.
Conclusions:
- A pancreatic oncofetal protein (POP) is present in both fetal pancreas and pancreatic carcinoma.
- POP can be detected using immunoelectrophoresis and is partially purified.
- The protein nature of POP suggests its potential as a diagnostic marker for pancreatic cancer.